GLIA Diagnostics

Our Team

The GLIA Team

GLIA Diagnostics brings together world-class expertise in clinical medicine, neuroscience, biomedical engineering, commercialisation, and manufacturing — united by a single purpose: delivering objective, rapid TBI diagnostics to the people who need them most.

A Multidisciplinary Team

Building a point-of-care molecular diagnostic platform requires deep expertise across multiple disciplines. The GLIA team combines decades of experience in emergency medicine, neurosurgery, biomedical R&D, intellectual property, commercialisation, and manufacturing — supported by strategic partnerships across Australia and internationally.

Edmond Sorich

CEO

40 years of biomedical experience across R&D, research, translation and diagnostics, including senior management and operations.

R&D leadershipDiagnostics translationSenior management & operations

Prof. Biswadev Mitra

Clinical Science Advisor

Head of Emergency Medicine Research, Alfred Hospital.

Emergency medicine researchClinical scienceAlfred Hospital

Prof. Jeffery Rosenfeld

Clinical Advisor

Senior Neurosurgeon, Alfred Hospital. Prof. Surgery, Monash University. Brig. General/Surgeon General, ADF Reserves.

NeurosurgeryMilitary medicineMonash University & ADF

Dr. Lee Miles

IP Advisor

Intellectual property strategy and protection for GLIA’s miRNA biomarker portfolio and point-of-care diagnostic platform.

Intellectual propertyPatent strategyBiomedical IP

David Basseal

Commercialisation Advisor

Leadership positions including Roche, Becton Dickinson & Abbott.

CommercialisationRocheBecton Dickinson & Abbott

Milind Raje

Manufacturing Advisor

Manufacturing, Regulatory Engineering, Supply chain.

ManufacturingRegulatory engineeringSupply chain

Key Achievements

  • Combining clinical, regulatory, commercialisation, manufacturing and emergency medicine expertise.
  • Exclusive worldwide miRNA biomarker licence. PoC owned IP.
  • 5 completed clinical studies
  • 4 peer-reviewed publications
  • ADF and US DoD-supported research and engagement
  • Global patent portfolio
  • NFL collaboration
  • ADF and US DoD engagement
  • Underway — NSW engineering and commercialisation partnerships (Genesys/Memjet)
  • A$1.5M+ cumulative non-dilutive support
  • US$250K private pre-seed investment

Key Stakeholders

  • The Alfred Hospital
  • CSIRO
  • ADF / US DoD
  • NFL MOU

NSW

  • Macquarie University
  • Genesys Electronics Design/Memjet
  • North Shore AFL
  • Connectivity TBI Australia
  • NSW Rugby
  • American Football Australia

* Supported by NSW-based engineering partners Genesys Electronics Design and Memjet.

Join Us in Transforming TBI Diagnostics

We are actively seeking clinical collaborators, research partners, and strategic investors. If you share our commitment to objective brain injury diagnostics, we’d like to hear from you.